Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cytomx Thera (CTMX)

Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Jazz Pharmaceuticals JAZZ announced that the FDA has granted accelerated approval to its intravenously administered drug zanidatamab for certain patients with biliary tract cancer (BTC). The drug will...

CTMX : 0.8900 (+2.71%)
JAZZ : 126.67 (+1.25%)
CSTL : 29.81 (+3.22%)
SPRO : 1.1600 (-2.52%)
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Shares of Grifols GRFS lost over 8% on Tuesday after the company’s board refused to endorse Canada-based Brookfield Asset Management’s offer to acquire its outstanding share capital for €6.45 billion...

CTMX : 0.8900 (+2.71%)
CSTL : 29.81 (+3.22%)
GRFS : 8.70 (+1.87%)
SPRO : 1.1600 (-2.52%)
CytomX Therapeutics: Q3 Earnings Snapshot

CytomX Therapeutics: Q3 Earnings Snapshot

CTMX : 0.8900 (+2.71%)
CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CTMX : 0.8900 (+2.71%)
CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

CTMX : 0.8900 (+2.71%)
CytomX Therapeutics: Q2 Earnings Snapshot

CytomX Therapeutics: Q2 Earnings Snapshot

CTMX : 0.8900 (+2.71%)
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins...

ONCY : 0.9541 (-2.64%)
ONC.TO : 1.33 (-2.92%)
VSTM : 4.00 (+1.78%)
CTMX : 0.8900 (+2.71%)
BNTX : 113.13 (+4.53%)
FGEN : 0.3954 (+2.12%)
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates

/CNW/ -- USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by...

ONCY : 0.9541 (-2.64%)
VSTM : 4.00 (+1.78%)
CTMX : 0.8900 (+2.71%)
BNTX : 113.13 (+4.53%)
FGEN : 0.3954 (+2.12%)
ONC.TO : 1.33 (-2.92%)
Stocks Set to Open Higher as Investors Await Key U.S. Inflation Data and Fed Speak

June S&P 500 E-Mini futures (ESM24) are up +0.12%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.25% this morning as trading resumed after the Memorial Day holiday, with investors looking ahead...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
DECK : 192.15 (+5.63%)
ROST : 146.09 (+2.19%)
AAPL : 229.87 (+0.59%)
WDAY : 267.75 (-0.12%)
INTU : 640.12 (-5.68%)
CRM : 342.02 (+1.86%)
DKS : 210.16 (+4.23%)
CHWY : 34.89 (-2.73%)
HPQ : 38.13 (+0.58%)
AI : 37.42 (+6.94%)
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 0.9541 (-2.64%)
CADL : 5.04 (+21.89%)
ABVC : 0.5488 (-0.20%)
CTMX : 0.8900 (+2.71%)
AMGN : 294.53 (+1.60%)
ONC.TO : 1.33 (-2.92%)

Barchart Exclusives

How to Invest for Kids: Understanding the Basics
A good way to show kids the value of compounding money is to ask if they’d rather have a $100 bill today or a penny that doubles every day for 30 days. They will be surprised to hear that in 30 days, that penny would be worth about $5.4 million dollars! Here's a guide to the types of accounts you can open for your children or grandchildren. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar